LE TRAITEMENT DE RELAIS DE LA TUBERCULOSE PULMONAIRE PAR ADMINISTRATION INTERMITTENTE DE RIFAMPICINE ET D'ETHAMBUTOL

Translated title of the contribution: The retreatment of pulmonary tuberculosis by intermittent administration of Rifampicin and Ethambutol

D. Larbaoui, P. Chaulet, J. Grosset

Research output: Contribution to journalArticlepeer-review

Abstract

In the present state of antituberculous chemotherapy, the intermittent administration of rifampicin and ethambutol, after a short period of daily administration, may be applicable to patients in whom the first line regime proved inefficient. Conditions should, however, be respected, particularly in developing countries. The use of these drugs should be strictly limited to specialised units able to understand the indications, to supervise the administration of the drug and to ensure close supervision of the patients. The cost of such a treatment should not be prohibitive and should not exceed the cost of a standard second line chemotherapy using classical reserve drugs.

Translated title of the contributionThe retreatment of pulmonary tuberculosis by intermittent administration of Rifampicin and Ethambutol
Original languageFrench
Pages (from-to)41-48
Number of pages8
JournalRevue Francaise des Maladies Respiratoires
Volume3
Issue number1
StatePublished - Jan 1 1975

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The retreatment of pulmonary tuberculosis by intermittent administration of Rifampicin and Ethambutol'. Together they form a unique fingerprint.

Cite this